Post Market Surveillance for Medical Device Manufacturers in the Middle East

Post Market surveillance (PMS) is a critical component for medical device manufacturers, ensuring that products remain safe and effective after they enter the market. This article explores the importance of PMS, how it integrates into a Quality Management System (QMS), and best practices for manufacturers, particularly in the Middle East region.

What is post market surveillance of medical devices? 

Post Market surveillance refers to the systematic process through which medical device manufacturers monitor their products once they are on the market. It involves the ongoing collection, analysis, and interpretation of data related to the device's performance and safety in real-world use. Key objectives of PMS include:

• Identifying safety issues: Detecting and addressing potential hazards related to the device’s design or use.
• Understanding device usage: Gaining insights into how the device is used by healthcare professionals and patients.
• Gathering clinical evidence: Collecting data to support commercial use cases, refine marketing strategies, and enhance product development.
• Ensuring regulatory compliance: Meeting legal requirements set by regulatory bodies.
• Driving product improvements: Using feedback to guide the development of new iterations or entirely new devices.

Why is post market surveillance so important?

Regulatory Compliance
Regulatory bodies globally, such as the EMA in Europe, FDA in the US and equivalent authorities in the Middle East, mandate PMS as part of the lifecycle management of medical devices. Compliance with these regulations is non-negotiable for market access and continued device use.

Patient Safety
The primary reason for stringent PMS requirements is to protect patient safety. Effective PMS can identify safety issues before they result in harm, thus preventing adverse events, including severe consequences like patient deaths or surgical delays.

Reputation Management
A single adverse event can damage a company’s reputation. Consistent PMS helps build trust with healthcare providers and patients, ensuring that devices are reliable and safe.

Product Development
Data collected through PMS is invaluable for innovation. It helps manufacturers avoid previous mistakes, streamline manufacturing processes, and accelerate the path to market for new products.

Operational Efficiency
PMS activities can highlight operational inefficiencies, such as difficulties in manufacturing or issues with suppliers, allowing companies to make informed changes.

How does post market surveillance fit into your QMS?

The Medical Device Directive (MDD), Medical Device Regulation (MDR), FDA’s Quality System Regulation (QSR) and ISO 13485:2016 require that PMS be an integral part of a company’s QMS. Relevant QMS processes include:

• Complaint Handling: Collecting, investigating, and responding to customer complaints.
• Nonconformance Management: Identifying and addressing deviations from specified requirements.
• Corrective Action and Preventive Action (CAPA): Implementing measures to correct issues and prevent their recurrence.
• Internal Auditing: Regularly reviewing processes to ensure compliance and effectiveness.

An interconnected and intuitive electronic QMS (eQMS) platform is essential for managing these processes effectively. It allows for seamless data collection, trend analysis, and proactive issue resolution.

What are the regulations governing post market surveillance in the Middle East?

The Middle East region has diverse regulatory frameworks governing medical devices, often aligning with international standards such as those set by the FDA and European Medicines Agency (EMA). For instance:

• Saudi Food and Drug Authority (SFDA): Requires thorough PMS activities to ensure device safety and efficacy.
• United Arab Emirates Ministry of Health and Prevention (MOHAP): Implements strict PMS requirements for medical devices.
• Gulf Health Council (GHC): Provides guidelines for PMS across Gulf Cooperation Council (GCC) countries.

Compliance with these regulations ensures market access and maintains product integrity.

Best practices for carrying out post market surveillance

Start Early: Consider PMS during the device development phase to avoid playing catch-up post-market. Proactive approach shall be used for it.

Strong Communication Chains: Ensure all complaints and feedback are logged and communicated effectively within the organization. This includes training staff on identifying and reporting complaints.

Utilize Modern Tools: Leverage eQMS platforms designed for the medical device industry to manage PMS data efficiently. This reduces the administrative burden and ensures data is actionable.

Regular Reviews: Conduct regular reviews of PMS data to identify trends and implement necessary changes proactively.

Stakeholder Engagement: Involve all relevant stakeholders, including suppliers, healthcare professionals, and regulatory bodies, in your PMS processes.

Continuous Improvement: Use PMS data to drive continuous improvement in product design, manufacturing processes, and overall quality management.

Strengthen your compliance with SGS expertise in the Middle East

Post Market Surveillance (PMS) is essential for medical device manufacturers in the Middle East, where regulatory environments are continually evolving. By integrating PMS into your Quality Management System (QMS), utilizing modern tools, and following best practices, you can ensure patient safety, maintain regulatory compliance, and drive continuous product improvement.

At SGS, we offer specialized certification and training courses tailored for medical device manufacturers and distributors in the Middle East. Our expert guidance helps you navigate the complex regulatory landscape, ensuring your products meet the highest standards of safety and quality.

Contact us today to learn more about how SGS can support your PMS efforts and help your organization stay ahead in the market. 

About SGS

We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for sustainability, quality and integrity. Our 99,600 employees operate a network of 2,600 offices and laboratories around the world.